• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于细胞学为滤泡性肿瘤的患者,行 lobectomy 可能不合适。

Lobectomy may not be suitable for patients with follicular neoplasm cytology.

机构信息

Department of Endocrinology and Metabolism, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey

Department of Endocrinology and Metabolism, School of Medicine, Ankara University, Ankara, Turkey

出版信息

Turk J Med Sci. 2020 Feb 13;50(1):8-11. doi: 10.3906/sag-1610-125.

DOI:10.3906/sag-1610-125
PMID:31340635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7080349/
Abstract

BACKGROUND/AIM: The most appropriate surgical management of follicular neoplasm/suspicious for follicular neoplasm (FN) lesions is still contradictory. We aimed to evaluate the data of our patients with follicular neoplasm treated with thyroidectomy.

MATERIALS AND METHODS

We retrospectively analyzed the data of 74 patients who were diagnosed with follicular neoplasm cytology (FN cytology) by fine needle aspiration biopsy (FNAB) and had undergone total thyroidectomy or lobectomy with isthmectomy (LwI).

RESULTS

We examined a total of 74 patients, of which 64 (83.7%) were female and 10 (16.3%) were male. The malignancy rate in the pathological examinations of these patients was 31/74 (41.9%). The most common cancer among the patients with malignancy was papillary thyroid carcinomas (PTC) (20/31, 65%). Among the subtypes of PTCs, 11 were classical PTC, 5 were a follicular variant of PTC, 2 were the oncocytic variant of PTC, 1 was the diffuse sclerosing variant, and 1 was a columnar cell variant of PTC.

CONCLUSION

Since most FN cytology has been pathologically diagnosed with papillary cancer and some papillary cancer subtypes have been unfavorable pathologically, total thyroidectomy should be the most suitable treatment option in this group. Lobectomy with LwI is not suitable for patients with FNAB-proven FN cytology.

摘要

背景/目的:滤泡性肿瘤/疑似滤泡性肿瘤(FN)病变的最佳手术治疗仍存在争议。我们旨在评估经甲状腺切除术治疗的滤泡性肿瘤患者的数据。

材料与方法

我们回顾性分析了 74 例经细针穿刺活检(FNAB)诊断为滤泡性肿瘤细胞学(FN 细胞学)并接受甲状腺全切除术或峡部切除术加对侧叶部分切除术(LwI)的患者的数据。

结果

我们共检查了 74 例患者,其中 64 例(83.7%)为女性,10 例(16.3%)为男性。这些患者的病理检查恶性率为 31/74(41.9%)。恶性患者中最常见的癌症是甲状腺乳头状癌(PTC)(20/31,65%)。在 PTC 的亚型中,11 例为经典 PTC,5 例为 PTC 的滤泡变体,2 例为 PTC 的嗜酸细胞变体,1 例为弥漫性硬化变体,1 例为 PTC 的柱状细胞变体。

结论

由于大多数 FN 细胞学已在病理上诊断为乳头状癌,而某些乳头状癌亚型在病理上预后不良,因此甲状腺全切除术应是该组患者最适合的治疗选择。对于 FNAB 证实为 FN 细胞学的患者,不适合行 LwI 加对侧叶部分切除术。

相似文献

1
Lobectomy may not be suitable for patients with follicular neoplasm cytology.对于细胞学为滤泡性肿瘤的患者,行 lobectomy 可能不合适。
Turk J Med Sci. 2020 Feb 13;50(1):8-11. doi: 10.3906/sag-1610-125.
2
Ultrasound and cytological characteristics of non-invasive follicular thyroid neoplasm with papillary-like nuclear features compared to papillary carcinomas.与甲状腺乳头状癌相比,具有甲状腺滤泡上皮细胞特征的非侵袭性滤泡性甲状腺肿瘤的超声和细胞学特征。
Ann Endocrinol (Paris). 2020 Feb;81(1):28-33. doi: 10.1016/j.ando.2019.10.004. Epub 2020 Jan 25.
3
Lobectomy in follicular thyroid neoplasms' treatment.甲状腺滤泡肿瘤的叶切除术治疗。
Int J Surg. 2013;11(9):919-22. doi: 10.1016/j.ijsu.2013.07.004. Epub 2013 Jul 14.
4
Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.贝塞斯达分类法是细针穿刺报告的重要指南,尤其对诊断甲状腺乳头状癌的侵袭性变体具有高度预测性。
Cytopathology. 2017 Aug;28(4):259-267. doi: 10.1111/cyt.12384. Epub 2016 Sep 25.
5
Patients with Indeterminate Thyroid Nodules at Cytology and Cancer at Histology Have a More Favorable Outcome Compared with Patients with Suspicious or Malignant Cytology.对于细胞学检查为不确定甲状腺结节但组织学检查为癌症的患者,其结局优于细胞学检查为可疑或恶性的患者。
Thyroid. 2018 Oct;28(10):1318-1324. doi: 10.1089/thy.2017.0522.
6
Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤能否通过细针穿刺与经典乳头状甲状腺癌和滤泡性腺瘤相鉴别?
Cancer Cytopathol. 2017 Jun;125(6):378-388. doi: 10.1002/cncy.21848. Epub 2017 Mar 10.
7
Digital image-assisted quantitative nuclear analysis improves diagnostic accuracy of thyroid fine-needle aspiration cytology.数字图像辅助定量核分析提高甲状腺细针抽吸细胞学诊断的准确性。
Cancer Cytopathol. 2019 Aug;127(8):501-513. doi: 10.1002/cncy.22120. Epub 2019 May 31.
8
Cytopathology of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: A comparative study with similar patterned papillary thyroid carcinoma variants.具有乳头样核特征的非侵袭性滤泡性甲状腺肿瘤的细胞病理学:与相似形态的甲状腺乳头状癌变体的比较研究
Cytopathology. 2018 Jun;29(3):233-240. doi: 10.1111/cyt.12537. Epub 2018 Apr 11.
9
Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.具有乳头样核特征的非侵袭性滤泡性甲状腺肿瘤与侵袭性乳头状甲状腺癌滤泡变体的细胞学、分子学及临床特征
Cancer Cytopathol. 2017 May;125(5):323-331. doi: 10.1002/cncy.21839. Epub 2017 Feb 13.
10
PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.PD-L1 和甲状腺细胞学:一个可能的诊断和预后标志物。
Cancer Cytopathol. 2020 Mar;128(3):177-189. doi: 10.1002/cncy.22224. Epub 2019 Dec 10.

引用本文的文献

1
Role of clinicopathologic and sonographic characteristics for the management of patients with cytological diagnosis of thyroid follicular neoplasm.临床病理及超声特征在甲状腺滤泡性肿瘤细胞学诊断患者管理中的作用
Gland Surg. 2024 Nov 30;13(11):1996-2009. doi: 10.21037/gs-24-337. Epub 2024 Nov 26.
2
Intraoperative Assessment of High-Risk Thyroid Nodules Based on Electrical Impedance Measurements: A Feasibility Study.基于电阻抗测量的高危甲状腺结节术中评估:一项可行性研究
Diagnostics (Basel). 2022 Nov 25;12(12):2950. doi: 10.3390/diagnostics12122950.
3
Risk of malignancy in thyroid nodules with indeterminate (THY3f) cytology.甲状腺结节不典型(THY3f)细胞学检查的恶性风险。
Ann R Coll Surg Engl. 2022 Nov;104(9):703-709. doi: 10.1308/rcsann.2021.0358. Epub 2022 Apr 21.

本文引用的文献

1
Total thyroidectomy versus hemithyroidectomy for patients with follicular neoplasm. A cost-utility analysis.甲状腺全切除术与甲状腺叶切除术治疗滤泡性肿瘤患者:成本效用分析。
Int J Surg. 2014;12(8):837-42. doi: 10.1016/j.ijsu.2014.07.005. Epub 2014 Jul 11.
2
Controversies in the surgical management of thyroid follicular neoplasms. Retrospective analysis of 721 patients.甲状腺滤泡性肿瘤外科处理的争议。721 例患者的回顾性分析。
Int J Surg. 2014;12 Suppl 1:S29-34. doi: 10.1016/j.ijsu.2014.05.013. Epub 2014 May 22.
3
Lobectomy in follicular thyroid neoplasms' treatment.甲状腺滤泡肿瘤的叶切除术治疗。
Int J Surg. 2013;11(9):919-22. doi: 10.1016/j.ijsu.2013.07.004. Epub 2013 Jul 14.
4
Cost effectiveness of intraoperative pathology examination during diagnostic hemithyroidectomy for unilateral follicular thyroid neoplasms.单侧滤泡性甲状腺肿瘤行诊断性甲状腺部分切除术时术中病理检查的成本效益。
J Am Coll Surg. 2013 Oct;217(4):702-10. doi: 10.1016/j.jamcollsurg.2013.05.008. Epub 2013 Jun 28.
5
Thyroid lobectomy for indeterminate FNA: not without consequences.甲状腺叶切除术治疗不确定的细针穿刺抽吸活检:并非没有后果。
J Surg Res. 2013 Sep;184(1):189-92. doi: 10.1016/j.jss.2013.05.076. Epub 2013 Jun 11.
6
Fine needle aspiration cytology of thyroid follicular neoplasm: cytohistologic correlation and accuracy.甲状腺滤泡性肿瘤的细针穿刺细胞学检查:细胞组织学相关性及准确性
Korean J Pathol. 2013 Feb;47(1):61-6. doi: 10.4132/KoreanJPathol.2013.47.1.61. Epub 2013 Feb 25.
7
The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis.《甲状腺细胞病理学报告的贝塞斯达系统:一项荟萃分析》
Acta Cytol. 2012;56(4):333-9. doi: 10.1159/000339959. Epub 2012 Jul 25.
8
Surveillance and intervention after thyroid lobectomy.甲状腺叶切除术后的监测与干预。
Ann Surg Oncol. 2011 Jun;18(6):1729-33. doi: 10.1245/s10434-010-1544-8. Epub 2011 Jan 19.
9
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.美国甲状腺协会修订的甲状腺结节和分化型甲状腺癌患者管理指南。
Thyroid. 2009 Nov;19(11):1167-214. doi: 10.1089/thy.2009.0110.
10
The Bethesda System For Reporting Thyroid Cytopathology.甲状腺细胞病理学报告的贝塞斯达系统。
Am J Clin Pathol. 2009 Nov;132(5):658-65. doi: 10.1309/AJCPPHLWMI3JV4LA.